Skip to main content
Top
Published in: Journal of Assisted Reproduction and Genetics 7/2014

01-07-2014 | Assisted Reproduction Technologies

Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome

Authors: Amanda Ryan, Shunping Wang, Ruben Alvero, Alex J Polotsky

Published in: Journal of Assisted Reproduction and Genetics | Issue 7/2014

Login to get access

Abstract

Purpose

To determine if etiology of infertility modifies the relationship between the duration of ovarian stimulation and success during assisted reproductive technology (ART) cycles.

Methods

A prospectively collected database was analyzed in an academic infertility practice. Eight hundred and twelve infertile women undergoing their initial fresh embryo, non-donor in vitro fertilization (IVF) or Intracytoplasmic Sperm Injection ICSI) cycle between January 1999 and December 2010 were evaluated. Clinical pregnancy was the main outcome measured.

Results

Out of 663 cycles resulting in oocyte retrieval, 299 produced a clinical pregnancy (45.1%). Women who achieved a clinical pregnancy had a significantly shorter stimulation length (11.9 vs. 12.1 days, p=0.047). Polycystic ovary syndrome (PCOS) was the only etiology of infertility that was significantly associated with a higher chance for clinical pregnancy and was a significant confounder for the association of duration and success of treatment. Women with 13 days or longer of stimulation had a 34 % lower chance of clinical pregnancy as compared to those who had a shorter cycle (OR 0.66, 95% CI:0.46-0.95) after adjustment for age, ovarian reserve, number of oocytes retrieved, embryos transferred and PCOS diagnosis.

Conclusion

Prolonged duration of stimulation is associated with decreased ART success for all couples, except for women with PCOS.
Literature
2.
go back to reference Kushnir VA, Vidali A, Barad DH, Gleicher N. The status of public reporting of clinical outcomes in assisted reproductive technology. Fertility and Sterility 2013;100:736–741. Kushnir VA, Vidali A, Barad DH, Gleicher N. The status of public reporting of clinical outcomes in assisted reproductive technology. Fertility and Sterility 2013;100:736–741.
3.
go back to reference Younglai EV, Holloway AC, Foster WG. Environmental and occupational factors affecting fertility and IVF success. Hum Reprod Update. 2005;11:43–57.PubMedCrossRef Younglai EV, Holloway AC, Foster WG. Environmental and occupational factors affecting fertility and IVF success. Hum Reprod Update. 2005;11:43–57.PubMedCrossRef
4.
go back to reference Chuang M, Zapantis A, Taylor M, Jindal SK, Neal-Perry GS, Lieman HJ, et al. Prolonged gonadotropin stimulation is associated with decreased ART success. J Assist Reprod Genet. 2010;27:711–7.PubMedCentralPubMedCrossRef Chuang M, Zapantis A, Taylor M, Jindal SK, Neal-Perry GS, Lieman HJ, et al. Prolonged gonadotropin stimulation is associated with decreased ART success. J Assist Reprod Genet. 2010;27:711–7.PubMedCentralPubMedCrossRef
5.
go back to reference Baker VL, Luke B, Brown MB, Alvero R, Frattarelli JL, Usadi R, et al. Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the society for assisted reproductive technology clinic outcomes reporting system. Fertil Steril. 2010;94:1410–6.PubMedCrossRef Baker VL, Luke B, Brown MB, Alvero R, Frattarelli JL, Usadi R, et al. Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the society for assisted reproductive technology clinic outcomes reporting system. Fertil Steril. 2010;94:1410–6.PubMedCrossRef
6.
go back to reference Urman B, Tiras B, Yakin K. Assisted reproduction in the treatment of polycystic ovarian syndrome. Reprod Biomed Online. 2004;8:419–30.PubMedCrossRef Urman B, Tiras B, Yakin K. Assisted reproduction in the treatment of polycystic ovarian syndrome. Reprod Biomed Online. 2004;8:419–30.PubMedCrossRef
7.
go back to reference Mulders AG, Laven JS, Imani B, Eijkemans MJ, Fauser BC. IVF outcome in anovulatory infertility (WHO group 2)–including polycystic ovary syndrome–following previous unsuccessful ovulation induction. Reprod Biomed Online. 2003;7:50–8.PubMedCrossRef Mulders AG, Laven JS, Imani B, Eijkemans MJ, Fauser BC. IVF outcome in anovulatory infertility (WHO group 2)–including polycystic ovary syndrome–following previous unsuccessful ovulation induction. Reprod Biomed Online. 2003;7:50–8.PubMedCrossRef
8.
go back to reference Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RM. Fertilization and early embryology: normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod. 1995;10:2125–35.PubMed Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RM. Fertilization and early embryology: normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod. 1995;10:2125–35.PubMed
9.
go back to reference Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12:13–21.PubMedCrossRef Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12:13–21.PubMedCrossRef
10.
11.
go back to reference Homburg R, Howles C. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rational, results, reflections refinements. Hum Reprod Update. 1999;5:493–9.PubMedCrossRef Homburg R, Howles C. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rational, results, reflections refinements. Hum Reprod Update. 1999;5:493–9.PubMedCrossRef
12.
go back to reference Andoh K, Mizunuma H, Liu X, Kamijo T, Yamada K, Ibuki Y. A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human menopausal gonadotropin for patients with polycystic ovary syndrome. Fertil Steril. 1998;70:840–6.PubMedCrossRef Andoh K, Mizunuma H, Liu X, Kamijo T, Yamada K, Ibuki Y. A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human menopausal gonadotropin for patients with polycystic ovary syndrome. Fertil Steril. 1998;70:840–6.PubMedCrossRef
13.
go back to reference Tanbo T, Åbyholm T, Bjøro T, Dale PO. Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders. Hum Reprod. 1990;5:811–5.PubMed Tanbo T, Åbyholm T, Bjøro T, Dale PO. Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders. Hum Reprod. 1990;5:811–5.PubMed
14.
go back to reference Okohue J, Onuh S, Ikimalo J. Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility. Niger J Clin Pract. 2013;16:207–10.PubMedCrossRef Okohue J, Onuh S, Ikimalo J. Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility. Niger J Clin Pract. 2013;16:207–10.PubMedCrossRef
15.
go back to reference Beydoun HA, Stadtmauer L, Beydoun MA, Russell H, Zhao Y, Oehninger S. Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies. Reprod Biomed Online. 2009;18:856–63.PubMedCentralPubMedCrossRef Beydoun HA, Stadtmauer L, Beydoun MA, Russell H, Zhao Y, Oehninger S. Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies. Reprod Biomed Online. 2009;18:856–63.PubMedCentralPubMedCrossRef
16.
go back to reference Dale PO, Tanbo T, Åbyholm T. In-vitro fertilization in infertile women with the polycystic ovarian syndrome. Hum Reprod. 1991;6:238–41.PubMed Dale PO, Tanbo T, Åbyholm T. In-vitro fertilization in infertile women with the polycystic ovarian syndrome. Hum Reprod. 1991;6:238–41.PubMed
17.
go back to reference Swanton A, Storey L, McVeigh E, Child T. IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol. 2010;149:68–71.PubMedCrossRef Swanton A, Storey L, McVeigh E, Child T. IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol. 2010;149:68–71.PubMedCrossRef
18.
go back to reference Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89:318–23.PubMedCrossRef Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89:318–23.PubMedCrossRef
19.
go back to reference Pall M, Stephens K, Azziz R. Family size in women with polycystic ovary syndrome. Fertil Steril. 2006;85:1837–9.PubMedCrossRef Pall M, Stephens K, Azziz R. Family size in women with polycystic ovary syndrome. Fertil Steril. 2006;85:1837–9.PubMedCrossRef
20.
go back to reference Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril. 2008;89:1694–701.PubMedCentralPubMedCrossRef Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril. 2008;89:1694–701.PubMedCentralPubMedCrossRef
21.
go back to reference Chen SL, Sun L, Kong LH, Li L, Li J, Zhu L, et al. Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization. Zhonghua Fu Chan Ke Za Zhi. 2007;42:526–9.PubMed Chen SL, Sun L, Kong LH, Li L, Li J, Zhu L, et al. Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization. Zhonghua Fu Chan Ke Za Zhi. 2007;42:526–9.PubMed
22.
go back to reference Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online. 2011;23:421–39.PubMedCrossRef Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online. 2011;23:421–39.PubMedCrossRef
23.
go back to reference Jungheim ES, Lanzendorf SE, Odem RR, Moley KH, Chang AS, Ratts VS. Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome. Fertil Steril. 2009;92:256–61.PubMedCentralPubMedCrossRef Jungheim ES, Lanzendorf SE, Odem RR, Moley KH, Chang AS, Ratts VS. Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome. Fertil Steril. 2009;92:256–61.PubMedCentralPubMedCrossRef
25.
go back to reference Navot D, Rosenwaks Z, Margalioth E. Prognostic assessment of female fecundity. Lancet. 1987;330:645–7.CrossRef Navot D, Rosenwaks Z, Margalioth E. Prognostic assessment of female fecundity. Lancet. 1987;330:645–7.CrossRef
Metadata
Title
Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome
Authors
Amanda Ryan
Shunping Wang
Ruben Alvero
Alex J Polotsky
Publication date
01-07-2014
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 7/2014
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-014-0253-9

Other articles of this Issue 7/2014

Journal of Assisted Reproduction and Genetics 7/2014 Go to the issue